CPRX vs. CL
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPRX or CL.
Key characteristics
CPRX | CL | |
---|---|---|
YTD Return | 4.16% | 23.25% |
1Y Return | 30.57% | 27.04% |
3Y Return (Ann) | 46.82% | 7.65% |
5Y Return (Ann) | 29.11% | 8.13% |
10Y Return (Ann) | 22.08% | 6.10% |
Sharpe Ratio | 0.68 | 1.95 |
Daily Std Dev | 43.38% | 14.16% |
Max Drawdown | -94.25% | -67.63% |
Current Drawdown | -16.82% | -2.31% |
Fundamentals
CPRX | CL | |
---|---|---|
Market Cap | $2.07B | $79.25B |
EPS | $0.56 | $3.15 |
PE Ratio | 31.27 | 30.67 |
PEG Ratio | 0.00 | 2.15 |
Total Revenue (TTM) | $311.77M | $14.93B |
Gross Profit (TTM) | $260.21M | $8.86B |
EBITDA (TTM) | $58.77M | $3.63B |
Correlation
The correlation between CPRX and CL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CPRX vs. CL - Performance Comparison
In the year-to-date period, CPRX achieves a 4.16% return, which is significantly lower than CL's 23.25% return. Over the past 10 years, CPRX has outperformed CL with an annualized return of 22.08%, while CL has yielded a comparatively lower 6.10% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPRX vs. CL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CPRX vs. CL - Dividend Comparison
CPRX has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 2.03%.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CL Colgate-Palmolive Company | 2.03% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% | 2.05% | 2.04% |
Drawdowns
CPRX vs. CL - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than CL's maximum drawdown of -67.63%. Use the drawdown chart below to compare losses from any high point for CPRX and CL. For additional features, visit the drawdowns tool.
Volatility
CPRX vs. CL - Volatility Comparison
Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 8.60% compared to Colgate-Palmolive Company (CL) at 3.90%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CPRX vs. CL - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities